Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Int J Cancer
    March 2026
  1. MEDEIROS ABD, Dos Santos GO, Casali-da-Rocha JC, Junior SA, et al
    KRAS-G12C: The neglected biomarker to detect patients with MUTYH-associated polyposis.
    Int J Cancer. 2026;158:1588-1598.
    >> Share

  2. CUI J, Mukherjee A, Patel PG, Junkins A, et al
    Sex and organ-specific risk and temporal trends of human papillomavirus-associated anogenital cancer among solid organ transplant recipients in the United States.
    Int J Cancer. 2026;158:1507-1516.
    >> Share

    February 2026
  3. LAN YQ, Hua MW, Peng S, Wang XL, et al
    Total neoadjuvant therapy with six versus four cycles of CAPOX in locally advanced rectal cancer: A real-world study.
    Int J Cancer. 2026;158:1031-1041.
    >> Share

  4. LUNENBERG RA, Franken IA, van der Baan FH, Sijtsma FPC, et al
    A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands.
    Int J Cancer. 2026;158:963-976.
    >> Share

  5. JAKOBSEN AV, Kronborg C, Ramlov A, Hvid CA, et al
    The prognostic value of cell-free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus.
    Int J Cancer. 2026;158:790-798.
    >> Share

  6. GUADALAJARA H, Dominguez-Tristancho JL, Mateo RF, Leon-Arellano M, et al
    Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient-centered approach that clusters two cohorts with different outcomes.
    Int J Cancer. 2026;158:697-706.
    >> Share

    January 2026
  7. VAN LIERE ELSA, Ramsoekh D, Stewart TK, Daulton E, et al
    The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome-A prospective longitudinal study.
    Int J Cancer. 2026;158:257-266.
    >> Share

  8. KARKKAINEN M, Sievanen T, Korhonen TM, Tuomikoski J, et al
    Integrative omics approaches to uncover liquid-based cancer-predicting biomarkers in Lynch syndrome.
    Int J Cancer. 2026;158:243-256.
    >> Share

    December 2025
  9. ALI E, Ye W, Pavlov S, Cervenkova L, et al
    Distribution and prognostic value of T-cells in primary colorectal cancer and adjacent non-tumor mucosa in stage IV versus stage I-III patients.
    Int J Cancer. 2025 Dec 30. doi: 10.1002/ijc.70319.
    >> Share

  10. YU Z, Derksen M, Te Pas BM, Ladstatter S, et al
    Single-cell multi-omics characterize colorectal tumors, adjacent healthy tissue and matched (tumor) organoids identifying CRC-unique features.
    Int J Cancer. 2025;157:2619-2634.
    >> Share

  11. ORANGE ST, Dodd E, Nath S, Bowden H, et al
    Exercise serum promotes DNA damage repair and remodels gene expression in colon cancer cells.
    Int J Cancer. 2025 Dec 12. doi: 10.1002/ijc.70271.
    >> Share

    November 2025
  12. HJORTH CF, Olsen MH, Ulrichsen SP, Nors J, et al
    Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark.
    Int J Cancer. 2025 Nov 21. doi: 10.1002/ijc.70248.
    >> Share

  13. HARAGUCHI E, Akiyoshi T, Noguchi T, Sakamoto T, et al
    Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer.
    Int J Cancer. 2025;157:2146-2155.
    >> Share

  14. HORESH N, Dourado J, Rogers P, Aeschbacher P, et al
    Fragility Index analysis for robustness of evidence in Randomized Controlled Trials in National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer.
    Int J Cancer. 2025;157:1864-1875.
    >> Share

    October 2025
  15. JIANG R, Xing S, Wang X, Chen S, et al
    Association between TyG-related indices and colorectal cancer risk: A prospective cohort study.
    Int J Cancer. 2025 Oct 31. doi: 10.1002/ijc.70222.
    >> Share

  16. HEISSER T, Cardoso R, Niedermaier T, Hoffmeister M, et al
    Optimizing colonoscopy-based colorectal cancer screening by low-barrier, low-threshold pretesting.
    Int J Cancer. 2025 Oct 9. doi: 10.1002/ijc.70187.
    >> Share

  17. VANACLOCHA-ESPI M, Romeo-Cervera P, Castan-Cameo S, Perez-Sanz E, et al
    Risk of advanced adenoma detection in colorectal cancer screening programmes according to personal characteristics and screening history.
    Int J Cancer. 2025 Oct 6. doi: 10.1002/ijc.70182.
    >> Share

  18. VAN ERNING FN, Galanos LJK, Lurvink R, Aarts MJ, et al
    Socioeconomic differences among patients with stage I-III colon cancer: Detection, treatment and relative survival.
    Int J Cancer. 2025 Oct 2. doi: 10.1002/ijc.70181.
    >> Share

    September 2025
  19. VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al
    Pre- and post-diagnostic meat intake in relation to risk of recurrence and mortality among individuals with stage I-III colorectal cancer.
    Int J Cancer. 2025 Sep 18. doi: 10.1002/ijc.70113.
    >> Share

  20. DOMINGUEZ-ROVIRA X, Arnau-Collell C, Gonfaus-Ortiz G, Llargues-Sistac G, et al
    Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndrome.
    Int J Cancer. 2025;157:1154-1167.
    >> Share

  21. POTTHOFF K, Uhlig J, Jacobasch L, Muller L, et al
    Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VA
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70139.
    >> Share

  22. LI C
    Comments on "Early-life anthropometry and colorectal cancer risk in adulthood: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis of prospective studies".
    Int J Cancer. 2025 Sep 2. doi: 10.1002/ijc.70131.
    >> Share

  23. BRITO-ROCHA T, Constancio V, Leite-Silva P, Carvalho-Maia C, et al
    Multi-cancer early detection via a DNA methylation multiplex ddPCR-based blood test.
    Int J Cancer. 2025;157:1006-1019.
    >> Share

    August 2025
  24. RAJTMAJEROVA M, Ambrozkiewicz F, Hlavac V, Trailin A, et al
    Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases.
    Int J Cancer. 2025 Aug 30. doi: 10.1002/ijc.70116.
    >> Share

  25. PHAM TT, Nimptsch K, Aleksandrova K, Jenab M, et al
    Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
    Int J Cancer. 2025 Aug 26. doi: 10.1002/ijc.70090.
    >> Share

  26. LI T, Li Y, Yin L, Li W, et al
    Folic acid fortification and late-onset colorectal cancer risk: A systematic assessment of the worldwide evidence.
    Int J Cancer. 2025 Aug 25. doi: 10.1002/ijc.70109.
    >> Share

  27. YUAN T, Tagscherer KE, Roth W, Bewerunge-Hudler M, et al
    Methylation-based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population-based cohort.
    Int J Cancer. 2025 Aug 19. doi: 10.1002/ijc.70086.
    >> Share

  28. PIRINI F, Calzari L, Tedaldi G, Tebaldi M, et al
    Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients.
    Int J Cancer. 2025;157:788-799.
    >> Share

  29. LARSEN PT, Jorgensen SF, Rasmussen M, Andersen B, et al
    Screening outcomes at second FIT screening in individuals with a first time negative FIT-result or low-risk adenomas: Results from a nationwide FIT screening program.
    Int J Cancer. 2025;157:698-708.
    >> Share

  30. HAAS CB, Ocampo R, Liu D, Zuniga M, et al
    Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082.
    >> Share

  31. KAUPPINEN AK, Olkinuora AP, Mecklin JP, Peltomaki PT, et al
    Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome.
    Int J Cancer. 2025 Aug 7. doi: 10.1002/ijc.70074.
    >> Share

  32. ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al
    Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms.
    Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046.
    >> Share

    July 2025
  33. BELLO-PEREZ M, Mascarell P, Fernandez-Gonzalez M, Garcia JA, et al
    ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology.
    Int J Cancer. 2025 Jul 24. doi: 10.1002/ijc.70050.
    >> Share

  34. TRIPATHI C, Tovar Perez JE, Kapoor S, Muhsin A, et al
    Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.
    Int J Cancer. 2025;157:355-370.
    >> Share

  35. LINSSEN JDG, Schafrat PJM, de Back TR, van Erning FN, et al
    Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20-year nationwide cohort study.
    Int J Cancer. 2025;157:218-231.
    >> Share

  36. RUGGIERO R, Ottaiano A, Tathode M, Sirica R, et al
    Genetic variants linked to type 2 diabetes in CDKN1B and TCF7L2 influence survival outcomes in metastatic colorectal cancer.
    Int J Cancer. 2025 Jul 14. doi: 10.1002/ijc.70035.
    >> Share

  37. VAN DER HAAR AVILA I, Zhang T, Lorrain V, Keuning E, et al
    Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer.
    Int J Cancer. 2025 Jul 7. doi: 10.1002/ijc.70031.
    >> Share

  38. WIND KL, Steffensen JH, Jakobsen AV, Kronborg C, et al
    Prognostic significance of pre-treatment immune-inflammation biomarkers in anal cancer: A study combining real-world data and a meta-analysis.
    Int J Cancer. 2025;157:193-200.
    >> Share

  39. MOLLER L, Szentkiralyi A, Eisfeld C, Wellmann I, et al
    Incidence trends and relative survival of colorectal neuroendocrine neoplasms: A population-based study using German cancer registry data.
    Int J Cancer. 2025;157:116-125.
    >> Share

    June 2025
  40. CHAPLIN A, Rodriguez RM, Barcelo-Nicolau M, Perez-Romero K, et al
    Plasma fatty acids depletion: A metabolic signature related to colon cancer.
    Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70015.
    >> Share

  41. SERGEEV D, Heisser T, Hoffmeister M, Brenner H, et al
    Potential for enhancing efficacy of screening colonoscopy by lowering starting ages and extending screening intervals: A modelling study for Germany.
    Int J Cancer. 2025;156:2303-2310.
    >> Share

  42. PASSEN CV, Krug J, Weiss L, Abdou MM, et al
    Integrin beta6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin.
    Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35504.
    >> Share

  43. KORSGAARD U, Kristensen MP, Garcia-Rodriguez JL, Kjaer-Frifeldt S, et al
    The prognostic potential of RNA in stage II colon cancer: Insights from a screened multicenter population-based cohort study.
    Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35507.
    >> Share

    May 2025
  44. VAN ZUTPHEN M, Verkaar AJCF, van Duijnhoven FJB, Voortman T, et al
    Early-life anthropometry and colorectal cancer risk in adulthood: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis of prospective studies.
    Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35461.
    >> Share

  45. STERPETTI G, Sterpetti AV
    Increased mortality from colorectal cancer in younger individuals: The preventive role of aspirin and statins.
    Int J Cancer. 2025 May 27. doi: 10.1002/ijc.35495.
    >> Share

    April 2025
  46. HOANG T, Choi MK, Oh JH, Kim J, et al
    Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta-analysis.
    Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35442.
    >> Share

  47. ZHOU Y, Fu M, Guan X, Wang C, et al
    Targeted plasma lipidomic profiles associated with colorectal cancer risk and effect modifications by common risk factors and particulate matter exposure.
    Int J Cancer. 2025 Apr 21. doi: 10.1002/ijc.35449.
    >> Share

  48. BLANKS RG, Alison RJ, Reeves GK
    Invitation for FOBt screening and colorectal cancer mortality: A prospective analysis in the Million Women Study cohort.
    Int J Cancer. 2025 Apr 11. doi: 10.1002/ijc.35437.
    >> Share

  49. GE X, Feng Y, Tan S, Mao W, et al
    Gestational colorectal cancer: Mechanisms, treatments, and prognosis.
    Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35425.
    >> Share

    March 2025
  50. JOHANNSEN IR, Boysen AK, Mortensen FV, Kirkegard J, et al
    Temporal trends in incidence and mortality of colorectal cancer in Denmark from 2007 to 2022.
    Int J Cancer. 2025 Mar 14. doi: 10.1002/ijc.35400.
    >> Share

  51. VAN NASSAU SCMW, Zwart K, van der Baan FH, Vink GR, et al
    Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.
    Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35410.
    >> Share

  52. DROSDOWSKY A, Lamb KE, Te Marvelde L, Gibbs P, et al
    Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data study.
    Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35414.
    >> Share

  53. KATSARA MA, van den Berg D, Spaander MCW, van Vuuren AJ, et al
    The impact of extended invitation intervals on stage distribution of screen-detected and interval cancer within the Dutch colorectal cancer screening program.
    Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35371.
    >> Share

    February 2025
  54. ZHANG Y, Song K, Zhou Y, Chen Y, et al
    Accuracy and long-term effectiveness of established screening modalities and strategies in colorectal cancer screening: An umbrella review.
    Int J Cancer. 2025 Feb 25. doi: 10.1002/ijc.35381.
    >> Share

  55. GALANOS LJK, Rijken A, Elferink MAG, Kok NFM, et al
    Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases.
    Int J Cancer. 2025 Feb 17. doi: 10.1002/ijc.35356.
    >> Share

  56. PEREMIQUEL-TRILLAS P, Martinez JM, Paytubi S, Frias-Gomez J, et al
    Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.
    Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35368.
    >> Share

  57. AL NAHAS A, Yammine Ghantous S, Morales Berstein F, Cakmak EK, et al
    Associations between degree of food processing and colorectal cancer risk in a large-scale European cohort.
    Int J Cancer. 2025 Feb 8. doi: 10.1002/ijc.35361.
    >> Share

  58. JIN F, Poynten IM, Hillman RJ, Law C, et al
    Does use of anal cytology as a triage test improve the performance of high-risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?
    Int J Cancer. 2025;156:575-586.
    >> Share

    January 2025
  59. BYRD DA, Damerell V, Gomez Morales MF, Hogue SR, et al
    The gut microbiome is associated with disease-free survival in stage I-III colorectal cancer patients.
    Int J Cancer. 2025 Jan 31. doi: 10.1002/ijc.35342.
    >> Share

  60. AKKUS E, Karaoglan BB, Kayaalp M, Turmus U, et al
    Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic disease.
    Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35336.
    >> Share

  61. HU X, Xie S, Yang Z, Zhao X, et al
    Aggressive characteristics of tumor deposits in colorectal cancer highlight the need for staging refinement in patients with 0-3 metastatic lymph nodes.
    Int J Cancer. 2025 Jan 20. doi: 10.1002/ijc.35306.
    >> Share

  62. OGUZ ERDOGAN AS, Simmer F, Nagtegaal ID
    Tumor deposits should not be placed in the M category of TNM: A comparative survival analysis using SEER data.
    Int J Cancer. 2025;156:274-279.
    >> Share

  63. DYER CEF, Jin F, Hillman RJ, Nyitray AG, et al
    Self-collected versus clinician-collected anal swabs for anal cancer screening: A systematic review and meta-analysis.
    Int J Cancer. 2025;156:79-90.
    >> Share

    December 2024
  64. ADAMS J, Stebbing J
    Effects of MCL-1 expression in colorectal cancer.
    Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35308.
    >> Share

  65. MITTAL P, Battaglin F, Baca Y, Xiu J, et al
    Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes.
    Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35304.
    >> Share

  66. VAN STIGT BJ, Lansdorp-Vogelaar I, Spaander MCW, van Vuuren AJ, et al
    Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT-based colorectal cancer screening.
    Int J Cancer. 2024 Dec 19. doi: 10.1002/ijc.35294.
    >> Share

  67. HUNG FH, Peng HP, Hung CF, Hsieh LL, et al
    Performance evaluation of predictive models for detecting MMR gene mutations associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan.
    Int J Cancer. 2024;155:2201-2210.
    >> Share

  68. SONG Y, Ren S, Wu S, Liu W, et al
    Glucocorticoid promotes metastasis of colorectal cancer via co-regulation of glucocorticoid receptor and TET2.
    Int J Cancer. 2024 Dec 11. doi: 10.1002/ijc.35285.
    >> Share

  69. FORSTI A, Ambrozkiewicz F, Marciniak M, Lubinski J, et al
    Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers.
    Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35283.
    >> Share

  70. CAI R, Ke L, Zhao Y, Zhao J, et al
    NMR-based metabolomics combined with metabolic pathway analysis reveals metabolic heterogeneity of colorectal cancer tissue at different anatomical locations and stages.
    Int J Cancer. 2024 Dec 4. doi: 10.1002/ijc.35273.
    >> Share

    November 2024
  71. SHAHRIVAR M, Dietrich CE, Glimelius B, Saraste D, et al
    Type II diabetes and metformin use does not affect colorectal cancer prognosis.
    Int J Cancer. 2024 Nov 27. doi: 10.1002/ijc.35266.
    >> Share

  72. LU SSM, Rutegard M, Haggstrom C, Gylfe A, et al
    Prior antibiotics exposure is associated with an elevated risk of surgical site infections, including anastomotic leakage, after colon cancer but not rectal cancer surgery: A register-based study of 38,839 patients.
    Int J Cancer. 2024 Nov 27. doi: 10.1002/ijc.35269.
    >> Share

  73. FENG X, Yao Q, Xu Y, Zhang J, et al
    Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma.
    Int J Cancer. 2024;155:1780-1791.
    >> Share

  74. REICHMANN R, Nimptsch K, Pischon T, Gunter MJ, et al
    Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35205.
    >> Share

  75. TRAILIN A, Ali E, Ye W, Pavlov S, et al
    Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35252.
    >> Share

  76. SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al
    Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Int J Cancer. 2024;155:1567-1576.
    >> Share

    October 2024
  77. SONG CH, Kim N, Nam RH, Choi SI, et al
    Ninjurin1 deficiency differentially mitigates colorectal cancer induced by azoxymethane and dextran sulfate sodium in male and female mice.
    Int J Cancer. 2024 Oct 17. doi: 10.1002/ijc.35225.
    >> Share

    September 2024
  78. DAMERELL V, Klaassen-Dekker N, Brezina S, Ose J, et al
    Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer.
    Int J Cancer. 2024 Sep 23. doi: 10.1002/ijc.35183.
    >> Share


  79. Correction to "Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)".
    Int J Cancer. 2024 Sep 18. doi: 10.1002/ijc.35186.
    >> Share


  80. Expression of Concern: The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines.
    Int J Cancer. 2024;155:E9.
    >> Share

  81. NG L, Sin RW, Cheung DH, Wong CK, et al
    Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients.
    Int J Cancer. 2024 Sep 8. doi: 10.1002/ijc.35175.
    >> Share

  82. LONARE A, Raychaudhuri K, Shah S, Madhu G, et al
    14-3-3sigma restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer.
    Int J Cancer. 2024 Sep 6. doi: 10.1002/ijc.35176.
    >> Share

  83. NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al
    Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detection.
    Int J Cancer. 2024;155:925-933.
    >> Share

    August 2024
  84. STERPETTI AV, Borrelli V, Sapienza P, Campagnol M, et al
    Comments on "Differences in survival and recurrence of colorectal cancer by stage across population-based European registries".
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35150.
    >> Share

  85. NAKATSUMI H, Komatsu Y, Harada K, Kawamoto Y, et al
    A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801.
    Int J Cancer. 2024 Aug 14. doi: 10.1002/ijc.35116.
    >> Share

  86. VAN DE WEERD S, Torang A, van den Berg I, Lammers V, et al
    Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer.
    Int J Cancer. 2024 Aug 8. doi: 10.1002/ijc.35120.
    >> Share

    July 2024
  87. LI J, Roshelli Baker J, Aglago EK, Zhao Z, et al
    Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients.
    Int J Cancer. 2024 Jul 26. doi: 10.1002/ijc.35114.
    >> Share

  88. LU L, Zhang Q, Aladelokun O, Berardi D, et al
    Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer.
    Int J Cancer. 2024 Jul 22. doi: 10.1002/ijc.35104.
    >> Share

  89. WEI TT, Blanc E, Peidli S, Bischoff P, et al
    High-confidence calling of normal epithelial cells allows identification of a novel stem-like cell state in the colorectal cancer microenvironment.
    Int J Cancer. 2024 Jul 19. doi: 10.1002/ijc.35079.
    >> Share

  90. DANKNER R, Chetrit A, Avraham SB, Agay N, et al
    A historical cohort study with 27,754 individuals on the association between meat consumption and gastrointestinal tract and colorectal cancer incidence.
    Int J Cancer. 2024 Jul 19. doi: 10.1002/ijc.35084.
    >> Share

  91. RAFIQUE A, Ali I, Kim S, Farooq A, et al
    Toll-like receptor 13-mediated signaling protects against the development of colon cancer.
    Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35089.
    >> Share

  92. NISHIHARA K, Nakano S, Yamaji T, Goto A, et al
    Height, body mass index, physical activity, and risk of colorectal cancer in relation to expression of insulin receptor: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35075.
    >> Share

  93. HAMMARSTROM K, Nunes L, Mathot L, Mezheyeuski A, et al
    Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Int J Cancer. 2024;155:40-53.
    >> Share

    May 2024
  94. HOLTHUIJSEN DDB, van Roekel EH, Bours MJL, Ueland PM, et al
    Longitudinal associations of plasma kynurenines and ratios with fatigue and quality of life in colorectal cancer survivors up to 12 months post-treatment.
    Int J Cancer. 2024 May 23. doi: 10.1002/ijc.34992.
    >> Share

  95. WANG R, Lv C, Li D, Song Y, et al
    EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35039.
    >> Share

  96. HU M, Luo R, Yang K, Yu Y, et al
    Genomic landscape defines peritoneal metastatic pattern and related target of peritoneal metastasis in colorectal cancer.
    Int J Cancer. 2024 May 13. doi: 10.1002/ijc.35005.
    >> Share

  97. WANG P, Song M, Eliassen AH, Wang M, et al
    Identifying modifiable risk factors to prevent aggressive colorectal cancer.
    Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34993.
    >> Share

  98. VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al
    Associations between low- and high-fat dairy intake and recurrence risk in people with stage I-III colorectal cancer differ by sex and primary tumour location.
    Int J Cancer. 2024 May 3. doi: 10.1002/ijc.34959.
    >> Share

  99. HO VKY, Deijen CL, Hemmes B, van Erning FN, et al
    Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021).
    Int J Cancer. 2024;154:1569-1578.
    >> Share

  100. BECERRA-TOMAS N, Markozannes G, Cariolou M, Balducci K, et al
    Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34905.
    >> Share

  101. MARKOZANNES G, Becerra-Tomas N, Cariolou M, Balducci K, et al
    Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34903.
    >> Share

  102. CHAN DSM, Cariolou M, Markozannes G, Balducci K, et al
    Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34906.
    >> Share

  103. TSILIDIS KK, Markozannes G, Becerra-Tomas N, Cariolou M, et al
    Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34904.
    >> Share

    April 2024
  104. VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al
    Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977.
    >> Share

  105. ZHANG Y, Win AK, Makalic E, Buchanan DD, et al
    Associations between pathological features and risk of metachronous colorectal cancer.
    Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34979.
    >> Share

  106. FU X, Huang J, Zhu J, Fan X, et al
    Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model.
    Int J Cancer. 2024 Apr 9. doi: 10.1002/ijc.34946.
    >> Share

  107. BOUVIER AM, Jooste V, Lillini R, Marcos-Gragera R, et al
    Differences in survival and recurrence of colorectal cancer by stage across population-based European registries.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34944.
    >> Share

  108. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    >> Share

  109. MOEN L, Liu B, Bukirwa P, Chingonzoh T, et al
    Trends in the incidence of colorectal cancer in sub-Saharan Africa: A population-based registry study.
    Int J Cancer. 2024 Apr 3. doi: 10.1002/ijc.34942.
    >> Share

  110. BRENNER H, Weber L, Cardoso R, Heisser T, et al
    Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the COVID-19 pandemic.
    Int J Cancer. 2024 Apr 1. doi: 10.1002/ijc.34943.
    >> Share

    March 2024
  111. LI YJ, Wang X, Wu YJ, Zhou XY, et al
    Access to colorectal cancer screening in populations in China, 2020: A coverage-focused synthesis analysis.
    Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34938.
    >> Share

  112. DOHERTY N, Cardwell C, Murchie P, Hill C, et al
    Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study.
    Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937.
    >> Share

  113. TAN JY, Yeo YH, Ng WL, Fong ZV, et al
    How have US colorectal cancer mortality trends changed in the past 20 years?
    Int J Cancer. 2024 Mar 25. doi: 10.1002/ijc.34926.
    >> Share

  114. DAL MASO L, Toffolutti F, De Paoli A, Giudici F, et al
    Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
    Int J Cancer. 2024 Mar 23. doi: 10.1002/ijc.34923.
    >> Share

  115. ZNAOR A, Eser S, Bendahhou K, Shelpai W, et al
    Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
    Int J Cancer. 2024 Mar 8. doi: 10.1002/ijc.34895.
    >> Share

  116. HORESH N, Emile SH, Garoufalia Z, Gefen R, et al
    Trends in management and outcomes of colon cancer in the United States over 15 years: Analysis of the National Cancer Database.
    Int J Cancer. 2024 Mar 7. doi: 10.1002/ijc.34910.
    >> Share

  117. JEZIORSKI K
    Improving colon cancer screening in Poland. In search of the Holy Grail.
    Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34909.
    >> Share

    February 2024
  118. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    >> Share

    January 2024
  119. STIER EA, Clarke MA, Deshmukh AA, Wentzensen N, et al
    International Anal Neoplasia Society's consensus guidelines for anal cancer screening.
    Int J Cancer. 2024 Jan 31. doi: 10.1002/ijc.34850.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016